These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33896753)

  • 1. Letter to the editor regarding "Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease - A data from multi-institutional study in China".
    Li G; Wang T; Gou Y; Zeng R; Liu D; Duan Y; Liu B
    Int Immunopharmacol; 2021 Jun; 95():107631. PubMed ID: 33896753
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the editor regarding "Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease - A data from multi-institutional study in China".
    Liu X; Zhou K; Hua Y; Wang C
    Int Immunopharmacol; 2021 Jun; 95():107632. PubMed ID: 33903075
    [No Abstract]   [Full Text] [Related]  

  • 3. Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China.
    Li G; Wang T; Gou Y; Zeng R; Liu D; Duan Y; Liu B
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107037. PubMed ID: 33242833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
    Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Kong WX; Ma FY; Fu SL; Wang W; Xie CH; Zhang YY; Gong FQ
    World J Pediatr; 2019 Apr; 15(2):168-175. PubMed ID: 30809758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in an East China population.
    Tang Y; Yan W; Sun L; Huang J; Qian W; Ding Y; Lv H
    Clin Rheumatol; 2016 Nov; 35(11):2771-2776. PubMed ID: 27491972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases.
    Li X; Chen Y; Tang Y; Ding Y; Xu Q; Sun L; Qian W; Qian G; Qin L; Lv H
    Eur J Pediatr; 2018 Aug; 177(8):1279-1292. PubMed ID: 29948255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A retrospective analysis of 602 Kawasaki disease cases with electronic data capture system].
    Xie L; Zhou C; Wang R; Xiao T; Shen J; Huang M
    Zhonghua Er Ke Za Zhi; 2015 Jan; 53(1):34-9. PubMed ID: 25748402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Treatment for Kawasaki Disease: Challenges for Current and Future Therapies.
    McCrindle BW; Selamet Tierney ES
    J Pediatr; 2017 May; 184():7-10. PubMed ID: 28233548
    [No Abstract]   [Full Text] [Related]  

  • 10. A meta-analysis of re-treatment for intravenous immunoglobulin-resistant Kawasaki disease.
    Yang X; Liu G; Huang Y; Chen S; Du J; Jin H
    Cardiol Young; 2015 Aug; 25(6):1182-90. PubMed ID: 25597708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease.
    Lin MT; Chang CH; Sun LC; Liu HM; Chang HW; Chen CA; Chiu SN; Lu CW; Chang LY; Wang JK; Wu MH
    J Formos Med Assoc; 2016 May; 115(5):350-5. PubMed ID: 25910931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential protein analysis of serum exosomes post-intravenous immunoglobulin therapy in patients with Kawasaki disease.
    Zhang L; Song QF; Jin JJ; Huang P; Wang ZP; Xie XF; Gu XQ; Gao XJ; Jia HL
    Cardiol Young; 2017 Nov; 27(9):1786-1796. PubMed ID: 28803590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting IVIG resistance in UK Kawasaki disease.
    Davies S; Sutton N; Blackstock S; Gormley S; Hoggart CJ; Levin M; Herberg JA
    Arch Dis Child; 2015 Apr; 100(4):366-8. PubMed ID: 25670405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A machine learning approach to predict intravenous immunoglobulin resistance in Kawasaki disease patients: A study based on a Southeast China population.
    Wang T; Liu G; Lin H
    PLoS One; 2020; 15(8):e0237321. PubMed ID: 32853226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kawasaki disease in an 18-month-old boy.
    Wróblewska-Kałuzewska M; Kucińska B; Werner B
    Med Sci Monit; 2000; 6(6):1170-3. PubMed ID: 11208475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Options for Resistant Kawasaki Disease.
    Phuong LK; Curtis N; Gowdie P; Akikusa J; Burgner D
    Paediatr Drugs; 2018 Feb; 20(1):59-80. PubMed ID: 29101553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravenous immunoglobulin-resistant Kawasaki disease with hemophagocytosis].
    Servel AC; Vincenti M; Darras JP; Lalande M; Rodière M; Filleron A
    Arch Pediatr; 2012 Jul; 19(7):741-4. PubMed ID: 22652521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of responsiveness or non-responsiveness to treatment of acute Kawasaki disease using 1 gram per kilogram of immunoglobulin--an effective and cost-saving schedule of therapy.
    Ichihashi K; Shiraishi H; Momoi M
    Cardiol Young; 2009 Jun; 19(3):224-7. PubMed ID: 19272202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of red blood cell distribution width for coronary artery lesions in patients with Kawasaki disease.
    Xu H; Fu S; Wang W; Zhang Q; Hu J; Gao L; Zhu W; Gong F
    Cardiol Young; 2016 Aug; 26(6):1151-7. PubMed ID: 26435202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kawasaki disease in a patient with Wiskott-Aldrich syndrome: an increase in the platelet count.
    Kawakami C; Miyake M; Tamai H
    Int J Hematol; 2003 Feb; 77(2):199-200. PubMed ID: 12627860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.